When was Avoro Capital founded?

Avoro Capital was founded in 2009.

Where is Avoro Capital headquartered?

Avoro Capital is headquartered in New York, NY.

What is Avoro Capital's total asset value?

Avoro Capital has around in total assets under management.

How many investments has Avoro Capital made?

Avoro Capital has made 65 investments.

What has Avoro Capital invested in?

Avoro Capital has made numerous investments in companies like Ethyreal Bio , Whitehawk Therapeutics , and Hemab Therapeutics Holdings within the Biotechnology, Drug Discovery, and Holding Companies industries.

What has Avoro Capital invested in recently?

Avoro Capital's latest investment was on 10-Jun-2026 in Ethyreal Bio , a company within the Biotechnology industry.

Avoro Capital investment portfolio

Avoro Capital Overview

Investor Type

Venture Capital

Status

Active

Professionals

13

Investments

65

Portfolio

8

Exits

51

Avoro Capital General Information

Company Description

Founded in 2009, Avoro Capital is a venture capital firm based in New York. The firm provides investment advice and management to privately placed investment funds. The firm also provides investment advisory services to a separately managed account. The firm prefers to invest in making, primarily, long-term, early-stage investments in the equity and equity-related securities of healthcare companies, chiefly in the biotechnology subsector. The firm invests primarily in privately held companies.

Business Details

Website

avorocapital.com

Formerly Known As

venBio Select Advisor

Year Founded

2009

Investor Status

Actively Seeking New Investments

Primary Investor Type

Venture Capital

Other Investor Types

Hedge Fund

Corporate Office

110 Greene Street
Suite 800
New York, NY 10012
United States

+1 (212)



Avoro Capital Investments (65)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Ethyreal Bio	10-Jun-2026	Early Stage VC	Biotechnology	Pre-Clinical Trials
Whitehawk Therapeutics	12-May-2026		Drug Discovery	Generating Revenue
Hemab Therapeutics Holdings	27-Oct-2025		Holding Companies	Generating Revenue
Whitehawk Therapeutics	04-Mar-2025		Drug Discovery	Generating Revenue
Ottimo Pharma	19-Dec-2024		Drug Discovery	Generating Revenue
ViceBio	23-Sep-2024		Drug Discovery	Clinical Trials - Phase 1
Scorpion Therapeutics	16-Jul-2024		Drug Discovery	Generating Revenue
Krystal Biotech	22-May-2023		Drug Discovery	Generating Revenue
Tourmaline Bio	02-May-2023	Early Stage VC	Drug Discovery	Generating Revenue
Hemab Therapeutics Holdings	15-Feb-2023	Early Stage VC	Holding Companies	Generating Revenue

You’re viewing 10 of 65 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avoro Capital Exits (51)

Company Name	Exit Date	Exit Type
Scribe Therapeutics	24-Jul-2026	IPO
Hemab Therapeutics Holdings	01-May-2026
Mersana Therapeutics	06-Jan-2026
ViceBio	04-Dec-2025
Scorpion Therapeutics	01-Mar-2025
Monte Rosa Therapeutics	16-May-2024
Bellicum Pharmaceuticals	20-Feb-2024
Kymera Therapeutics	05-Jan-2024
Rocket Pharmaceuticals	13-Sep-2023	Public Investment 2nd Offering
Madrigal Pharmaceuticals	23-Dec-2022	PIPE

You’re viewing 10 of 51 exits. Get the full list »

Avoro Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.